We identified a mutation in CDC6 in the progenitor clone (Clone 1), implicating changes to the cell replication mechanism, and identified a mutation in TP53 and MAP3K8 in Clone 2, hinting at the proliferation of cancer beginning at Clone 2. The gene discussed is TP53; the disease is cancer.